L. Grislain
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Drug Solubulity and Delivery Systems
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Drug-Induced Hepatotoxicity and Protection 3
- Pharmacogenetics and Drug Metabolism 3
- Co-authors
- Patrick Couvreur (7 shared papers)Marie Cecilie Paasche Roland (3 shared papers)P Speiser (3 shared papers)Vincent Lenaerts (5 shared papers)Boubacar Kanté (1 shared paper)Th.J.C. van Berkel (1 shared paper)J. Fred Nagelkerke (1 shared paper)Claire Guyomard (2 shared papers)
- Journals
- Xenobiotica (2 papers)Journal of Pharmaceutical Sciences (2 papers)High Pressure Research (2 papers)Pharmaceutical Research (2 papers)Drug Metabolism and Disposition (1 paper)
- Partner nations
- FranceSwitzerlandBelgium
In The Last Decade
L. Grislain
21 papers receiving 722 citations
Peers
Comparison fields: 5 of 94
- Pharmaceutical Science 197
- Biomaterials 332
- Hepatology 57
- Pharmacology 45
- Oncology 94
Countries citing papers authored by L. Grislain
This map shows the geographic impact of L. Grislain's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Grislain with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Grislain more than expected).
Fields of papers citing papers by L. Grislain
This network shows the impact of papers produced by L. Grislain. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Grislain. The network helps show where L. Grislain may publish in the future.
Co-authors
The 25 scholars most cited alongside L. Grislain, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1983 | 282 | |
| 2 | 1982 | 196 | |
| 3 | 1984 | 101 | |
| 4 | 1992 | 44 | |
| 5 | 2003 | 24 | |
| 6 | 1990 | 24 | |
| 7 | 2011 | 20 | |
| 8 | 1991 | 16 | |
| 9 | 1990 | 15 | |
| 10 | 2003 | 12 | |
| 11 | 2018 | 11 | |
| 12 | 2019 | 9 | |
| 13 | 2007 | 9 | |
| 14 | 1990 | 7 | |
| 15 | 1988 | 4 | |
| 16 | 2002 | 3 | |
| 17 | 2003 | 3 | |
| 18 | 2003 | 3 | |
| 19 | 1986 | 3 | |
| 20 | 2002 | 2 |
About L. Grislain
L. Grislain is a scholar working on Pharmacology, Molecular Biology, Biotechnology, Biomedical Engineering and Pharmaceutical Science, having authored 23 papers that have together received 789 indexed citations. Recurring topics across this work include Microbial Inactivation Methods (4 papers), Drug-Induced Hepatotoxicity and Protection (3 papers), Nanoparticle-Based Drug Delivery (3 papers), Drug Solubulity and Delivery Systems (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Innovative Microfluidic and Catalytic Techniques Innovation (3 papers), Diet and metabolism studies (2 papers) and Liver physiology and pathology (2 papers). The work is most often cited by research in Pharmaceutical Science (197 citations), Biomaterials (332 citations), Hepatology (57 citations), Pharmacology (45 citations) and Oncology (94 citations). L. Grislain has collaborated with scholars based in France, Switzerland and Belgium. Frequent co-authors include Patrick Couvreur, Marie Cecilie Paasche Roland, P Speiser, Vincent Lenaerts, Boubacar Kanté, Th.J.C. van Berkel, J. Fred Nagelkerke, Claire Guyomard, Alain Fautrel and Christophe Chesné. Their work appears in journals such as Xenobiotica, Journal of Pharmaceutical Sciences, High Pressure Research, Pharmaceutical Research and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.